Posted on August 19th, 2010 by
Many elderly U.S. cancer patients were not given a drug that could improve chances of survival sixfold out of concern for minor side effects, a study says. Researchers at the University of New Mexico Cancer Center say oncologists showed reluctance to prescribe the drug imatinib for older sufferers of chronic myeloid leukemia, a relatively rare form of blood cancer diagnosed in about 4,500 new patients a year, The Albuquerque Journal reported Thursday. Link
Tags: In the News
You must be logged-in to the site to post a comment.